Skip to main content
SpringerLink
Log in

Pharmacology and Psychopharmacology

  • Chapter
  • First Online:
Psychiatric Disorders Late in Life

Abstract

Up-to-date knowledge of pathophysiological changes associated with aging and psychopharmacology are essential skills for clinicians caring for older adults with psychiatric disorders. This knowledge enables clinicians to make optimal use of psychotropic medications to treat psychiatric disorders in the older adult population. Maximizing the effectiveness of psychotropic medications and minimizing their adverse effect profile will enable older adults to have better treatment outcomes. This optimization of treatment will reduce the financial burden on an already stretched healthcare system. In this chapter we review essential aspects of geriatric pharmacology and psychopharmacology that will enable clinicians to optimize the treatment of older adults with psychiatric disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mental health and older adults. http://www.who.int/mediacentre/factsheets/fs381/en/. Accessed 10 Dec 2016.

  2. Aging Statistics. https://aoa.acl.gov/Aging_Statistics/index.aspx. Accessed 10 Dec 2016.

  3. Reynold K, Pietrzak RH, El-Gabalawy R, Mackenzie CS, Sareen J. Prevalence of psychiatric disorders in U.S. older adults: findings from a nationally representative survey. World Psychiatry. 2015;14(1):74–81.

    Article  Google Scholar 

  4. Aparasu RR, Mort JR, Brandt H. Psychotropic prescription use by community-dwelling elderly in the United States. J Am Geriatr Soc. 2003;51(5):671–7.

    Article  PubMed  Google Scholar 

  5. Molinari VA, Chiriboga DA, Branch LG, et al. Reasons for psychiatric medication prescription for new nursing home residents. Aging Ment Health. 2011;15(7):904–12.

    Article  PubMed  Google Scholar 

  6. García-Gollarte F, Baleriola-Júlvez J, Ferrero-López I, Cruz-Jentoft AJ. Inappropriate drug prescription at nursing home admission. J Am Med Dir Assoc. 2012;13(1):83.e9–15.

    Article  Google Scholar 

  7. Gurwitz JH, Field TS, Avorn J, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med. 2000;109(2):87–94.

    Article  CAS  PubMed  Google Scholar 

  8. Hartikainen S, Lönnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci. 2007;62(10):1172–81.

    Article  PubMed  Google Scholar 

  9. Peron EP, Gray SL, Hanlon JT. Medication use and functional status decline in older adults: a narrative review. Am J Geriatr Pharmacother. 2011;9(6):378–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Tampi RR, Williamson D, Mittal V, et al. Behavioral and psychological symptoms of dementia: part I—epidemiology, neurobiology, heritability, and evaluation. Clin Geriatr. 2011;19(5):41–6.

    Google Scholar 

  11. Tampi RR, Williamson D, Mittal V, et al. Behavioral and psychological symptoms of dementia: part II—treatment. Clin Geriatr. 2011;19(6):31–40.

    Google Scholar 

  12. By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–46.

    Article  Google Scholar 

  13. Pollock B, Forsyth C, Bies R. The critical role of clinical pharmacology in geriatric psychopharmacology. Clin Pharmacol Ther. 2009;85(1):89–93.

    Article  PubMed  Google Scholar 

  14. Golan DE, Tashjian AH, Armstrong AJ, Armstrong AW, editors. Principles of pharmacology: the pathophysiologic basis of drug therapy. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 19–49.

    Google Scholar 

  15. von Moltke LL, Abernethy DR, Greenblatt DJ. Kinetics and dynamics of psychotropic drugs in the elderly. In: Salzman C, editor. Clinical geriatric psychopharmacology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004. p. 87–114.

    Google Scholar 

  16. Madhusoodanan S, Velama U, Parmar J, Goia D, Brenner R. A current review of cytochrome P450 interactions of psychotropic drugs. Ann Clin Psychiatry. 2014;26(2):120–38.

    PubMed  Google Scholar 

  17. Caley CF. Interpreting and applying CYP450 genomic test results to psychotropic medications. J Pharm Pract. 2011;24(5):439–46.

    Article  PubMed  Google Scholar 

  18. Lynch T, Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician. 2007;76(3):391–6.

    PubMed  Google Scholar 

  19. Eap CB. Personalized prescribing: a new medical model for clinical implementation of psychotropic drugs. Dialogues Clin Neurosci. 2016;18(3):313–22.

    PubMed  PubMed Central  Google Scholar 

  20. Albers LJ, Hahn RK, Reist C. Handbook of psychiatric drugs. Blue Jay: Current Clinical Strategies Publishing; 2011. p. 8–110.

    Google Scholar 

  21. Labbate LA, Fava M, Rosenbaum JF, Arana GW. Handbook of psychiatric drug therapy. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2010. p. 1–254.

    Google Scholar 

  22. Perry R, Cassagnol M. Desvenlafaxine: a new serotonin-norepinephrine reuptake inhibitor for the treatment of adults with major depressive disorder. Clin Ther. 2009;31(Pt 1):1374–404.

    Article  CAS  PubMed  Google Scholar 

  23. Asnis GM, Henderson MA. Levomilnacipran for the treatment of major depressive disorder: a review. Neuropsychiatr Dis Treat. 2015;11:125–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. McCormack PL. Vilazodone: a review in major depressive disorder in adults. Drugs. 2015;75(16):1915–23.

    Article  CAS  PubMed  Google Scholar 

  25. Connolly KR, Thase ME. Vortioxetine: a new treatment for major depressive disorder. Expert Opin Pharmacother. 2016;17(3):421–31.

    Article  CAS  PubMed  Google Scholar 

  26. Jacobson LH, Callander GE, Hoyer D. Suvorexant for the treatment of insomnia. Expert Rev Clin Pharmacol. 2014;7(6):711–30.

    Article  CAS  PubMed  Google Scholar 

  27. Castillo EG, Stroup TS. Effectiveness of long-acting injectable antipsychotics: a clinical perspective. Evid Based Ment Health. 2015;18(2):36–9.

    Article  PubMed  Google Scholar 

  28. Reus VI, Fochtmann LJ, Eyler AE, Hilty DM, Horvitz-Lennon M, Jibson MD, Lopez OL, Mahoney J, Pasic J, Tan ZS, Wills CD, Rhoads R, Yager J. The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia. Am J Psychiatry. 2016;173(5):543–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Case Western Reserve University School of Medicine and Metrohealth, Cleveland, OH, USA

    Rajesh R. Tampi M.D., M.S., D.F.A.P.A. & Mallika Lavakumar M.D.

  2. Diamond Healthcare, Richmond, VA, USA

    Deena J. Tampi M.S.N., M.B.A.-H.C.A., R.N.

Authors
  1. Rajesh R. Tampi M.D., M.S., D.F.A.P.A.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Deena J. Tampi M.S.N., M.B.A.-H.C.A., R.N.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mallika Lavakumar M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rajesh R. Tampi M.D., M.S., D.F.A.P.A. .

Editor information

Editors and Affiliations

  1. Professor of Psychiatry, Case Western Reserve University School of Medicine, Vice Chairman for Education and Faculty Development, Residency Program Director and Chief of Geriatric Psychiatry, MetroHealth, Cleveland, Ohio, USA

    Rajesh R. Tampi

  2. Executive Vice President, Clinical Services, Diamond Healthcare, Richmond, Virginia, USA

    Deena J. Tampi

  3. Associate Clinical Professor of Psychiatry, University of Wisconsin School of Medicine and Public Health Program Director, Geriatric Psychiatry Fellowship, Madison, Wisconsin, USA

    Lisa L. Boyle

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tampi, R.R., Tampi, D.J., Lavakumar, M. (2018). Pharmacology and Psychopharmacology. In: Tampi, R., Tampi, D., Boyle, L. (eds) Psychiatric Disorders Late in Life. Springer, Cham. https://doi.org/10.1007/978-3-319-73078-3_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-73078-3_25

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-73076-9

  • Online ISBN: 978-3-319-73078-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation